Preparing Nurses on an Intermediate Care Unit to Assess and Manage Patients Undergoing Chimeric Antigen Receptor Therapy (CAR T) at an NCI Designated Academic Cancer Center

Chimeric Antigen Receptor Therapy (CAR T) is a dynamic rapidly developing area of cancer treatment. The delivery of this therapy is complex and many centers struggle with operationalizing the various phases of this treatment, including which specialty area is best equipped to administer, monitor and safely manage the patient for potentially life threatening side effects during each phase of therapy. Without a dedicated CAR T service, it was the determined that adult patients receiving this treatment would be best managed on our intermediate care leukemia/lymphoma unit.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Tags: 115 Source Type: research